McKesson Corporation Common Stock (MCK)
Stock · NYSE · Health Care
$893.39as of 8/28/2026
Price chart
Open in TradingViewAbout MCK
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to r…
- Sector
- Health Care
- Industry
- Other Pharmaceuticals
- Employees
- 41,600
- Website
- www.mckesson.com/
Fundamentals
- 1-day range
- $890.8$900.22
- Market cap
- $99.43B
- P/E (trailing)
- 21.89
- P/E (forward)
- 17.67
- EPS (trailing)
- $37.35
- Dividend yield
- 0.54%
- Beta
- 0.30
- Avg. volume
- 1.04M
- Ex-dividend date
- September 1, 2026
- Dividend pay date
- October 1, 2026
How McKesson Corporation Common Stock Makes Money
Where the revenue actually goes — FY2026 annual results
Source: 10-K filed May 8, 2026 · via SEC EDGAR / Finnhub
Forecasts
16 analyst ratings
McKesson Corporation Common Stock Competitors
Chosen by industry and closest market cap.
- MCKMcKesson Corporation Common Stock$894.35▲ 0.43%Market cap $99.43BP/E 21.89$677.28$999
- CORCencora Inc. Common Stock$322.02▲ 0.25%Market cap $60.00BP/E 22.54$244.82$377.54
- HLFHerbalife Ltd. Common Shares$12.43▲ 0.65%Market cap $1.32BP/E 7.68$7.56$20.4
- NUSNu Skin Enterprises Inc. Common Stock$4.85▲ 2.54%Market cap $250.52MP/E 4.30$4.49$14.62
- HKPDCellyan Biotechnology Co. Ltd Class A Ordinary Shares$0.36▼ 11.33%Market cap $16.93MP/E —$0.31$1.82
- SCNXScienture Holdings Inc. Common Stock$0.3938▲ 3.63%Market cap $15.72MP/E —$0.2382$2.6
- COSMCosmos Health Inc. Common Stock$0.225▲ 4.17%Market cap $14.59MP/E —$0.1616$1.32
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| MCK McKesson Corporation Common Stock | $99.43B | 21.89 | $894.35 | ▲ 0.43% | $677.28$999 |
| COR Cencora Inc. Common Stock | $60.00B | 22.54 | $322.02 | ▲ 0.25% | $244.82$377.54 |
| HLF Herbalife Ltd. Common Shares | $1.32B | 7.68 | $12.43 | ▲ 0.65% | $7.56$20.4 |
| NUS Nu Skin Enterprises Inc. Common Stock | $250.52M | 4.30 | $4.85 | ▲ 2.54% | $4.49$14.62 |
| HKPD Cellyan Biotechnology Co. Ltd Class A Ordinary Shares | $16.93M | — | $0.36 | ▼ 11.33% | $0.31$1.82 |
| SCNX Scienture Holdings Inc. Common Stock | $15.72M | — | $0.3938 | ▲ 3.63% | $0.2382$2.6 |
| COSM Cosmos Health Inc. Common Stock | $14.59M | — | $0.225 | ▲ 4.17% | $0.1616$1.32 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- McKesson Says It Discovered Cybersecurity Incident Affecting Its Information Systems On August 25; Investigation In Early Stages, Has Not Determined If Incident Is Materialbenzinga · 8/28/2026
- McKesson (MCK) Stock May Trade At A Discount As Cash Flow Holds UpYahoo · 8/21/2026
- McKesson (MCK) Joined A Tech Summit, Is It Still 13% Undervalued?Yahoo · 8/20/2026
- TCW Durable Growth ETF Q2 2026 Performance UpdateSeekingAlpha · 8/20/2026
- RBC Capital Initiates Coverage of McKesson (MCK) with Sector Perform RecommendationFintel · 8/20/2026
- Is HSIC Worth Buying as Growth Improves but Execution Risks Persist?Yahoo · 8/19/2026
- Moderna upgraded, Baidu downgraded: Wall Street's top analyst callsYahoo · 8/19/2026
- Winners And Losers Of Q2: McKesson (NYSE:MCK) Vs The Rest Of The Healthcare Providers & Services StocksYahoo · 8/19/2026
- Barclays Maintains Overweight on McKesson, Raises Price Target to $1000Benzinga · 8/19/2026
Insider Activity
Insider Actions →- Bradley E. Lerman · August 10, 2026 · Sale301 @ $892.33
- Srinivasan Ramesh (NMN) · August 7, 2026 · Grant368
- Hinton James H. · July 22, 2026 · Grant277
- Lynne M. Doughtie · July 22, 2026 · Grant277
- Gerberding Julie L. · July 22, 2026 · Grant277
- Maria Martinez · July 22, 2026 · Grant277 @ $814.04
- Bradley E. Lerman · July 22, 2026 · Grant277
- Kevin M. Ozan · July 22, 2026 · Grant277
- Dominic J. Caruso · July 22, 2026 · Grant277 @ $814.04
- Deborah Dunsire · July 22, 2026 · Grant277
- Kathleen Wilson-Thompson · July 22, 2026 · Grant277 @ $814.04
- Webster Roy Dunbar · July 22, 2026 · Grant277
- Brian S. Tyler · July 7, 2026 · Sale8.5K @ $793.56
- Brian S. Tyler · June 17, 2026 · Sale8.5K @ $775.13
- Brian S. Tyler · June 9, 2026 · Sale4.9K @ $763
Institutional Ownership
March 31, 2026
- Total shares held
- 99.69M
- Total value held
- $82.65B
- Institutional holders
- 2009
- Unknown11.43M
- Unknown7.96M
- Unknown5.73M
- Unknown3.60M
- Unknown3.06M
- Unknown2.90M
- Unknown2.90M
- Unknown2.30M
- Unknown2.24M
- Unknown1.54M
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedSynthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
August 29, 2026
McKesson Expands Into Precision Medicine With Acquisition. McKesson has agreed to acquire Precision Medicine Group, a move aimed at strengthening its clinical research and commercialization capabilities. The deal signals McKesson's intent to grow in higher-value specialty services rather than rely solely on its core drug distribution business. Separately, recent coverage highlighted McKesson's inclusion in dividend-focused stock screeners and reviewed its long-term return profile for shareholders. The acquisition comes as the stock trades well above its 52-week low but below its high, with analysts' average price target sitting above the current price level.